Skip to content
  • My Profile
  • Register
  • Log In
  • Watchlist
AlphaStreet

Market Intelligence Ecosystem

  • News
          • Technology
          • Consumer
          • Health Care
          • Industrials
          • Retail
          • Finance
          • Energy
          • IPO
          • Leisure & Entertainment
          • Research Summary
          • Other Industries
  • News
    • Consumer
    • Energy
    • Finance
    • Health Care
    • Industrials
    • IPO
    • Leisure & Entertainment
    • Other Industries
    • Research Summary
    • Retail
    • Technology
  • AlphaGraphs
  • AlphaStreet Intelligence
  • Log In
  • Register
  • My Profile
  • Watchlist

Categories

  • CEO Insights
  • Fund Manager Insights
  • Concall Highlights
  • Analysis
  • Concall Transcripts
  • AlphaGraphs

pharma stocks

Aurobindo Pharma Limited (NSE: AUROPHARMA): Q3 FY23 Results Out; Total Income Rises 7% YoY

February 9, 2023February 9, 2023

Aurobindo Pharma Limited (NSE: AUROPHARMA) is a pharmaceutical company based in Hyderabad, India. The company was founded in 1986 and has since

Divis Labs Ltd.(NSE:DIVISLAB )|Q3 FY23 Results Out|Total Income rises 5% yoy

February 3, 2023February 3, 2023

Divi's Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company

Infographic Ltd.(NSE: DRREDDY) | Q3 FY23 Results | Total Income rises +7.47% qoq

January 25, 2023January 25, 2023

Dr. Reddy's Laboratories (NSE: DRREDDY) is an Indian multinational pharmaceutical company. Founded in 1984, the company primarily develops and sells a wide

Infographic Cipla Ltd.(NSE: CIPLA) | Q3 FY23 Results | Total Income falls -0.45% qoq

January 25, 2023January 25, 2023

Cipla Limited (NSE: CIPLA) is an Indian multinational pharmaceutical and biopharmaceutical company. Founded in 1935, Cipla primarily develops and sells generic and

Gland Pharma Limited Q3 FY23; Net Profit Down To 232 Crore

January 23, 2023January 23, 2023

Gland Pharma Limited (NSE: GLAND) reported Revenue from Operations of ₹938.28 Crore down from ₹1,063.32 Crore year on year, a decline of

Marksans Pharma(NSE:MARKSANS): Everything You Need to Know | Stock up 30% in 3 Months

January 4, 2023January 4, 2023

Marksans Pharma (NSE:MARKSANS) is a mid-sized pharmaceutical company with a large presence in the US, UK, Australia, and New Zealand markets. forward-integrated

Everything You Need to Know About Brooks Laboratories Limited(NSE:BROOKS)| Stock UP 30% in 2 Months

November 20, 2022November 20, 2022

Brooks Laboratories Limited(NSE:BROOKS) has an industry presence of nearly two decades now, leading to established relationships with the customers as well as

Infographic : Brooks Labrotories (NSE : BROOKS) | Q4FY22 Results Released! | Revenue UP 94.55% YoY

November 18, 2022November 18, 2022

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both

Infographic : Brooks Labrotories (NSE : BROOKS) | Q1 Results Released! | Revenue DOWN 23.21% YoY

November 18, 2022November 18, 2022

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both

Infographic : Brooks Labrotories (NSE : BROOKS) | Q2 Results Released! | Revenue DOWN 15.74% YoY

November 18, 2022November 18, 2022

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both

Infographic : Gland Pharma Ltd (NSE : GLAND) Q2 Results; Total Revenue = ₹ 1110.28 million ( UP 19.7 % QoQ)

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral

Top 5 Stocks with 200% Profit Growth in 2022

September 3, 2022September 3, 2022

1. India Cements Ltd India Cements Ltd is a leading cement manufacturing company based in Chennai. It was founded in 1946 by

Aurobindo Pharma Limited Q1 FY 2023 Research Tear Sheet

August 15, 2022August 15, 2022

Stock Data Ticker: AUROPHARMA Exchange :NSE and BSE Industry: Automobile Price Performance Last 7 days    4.36% YTD                 -19.19% Last 12 months     -28.17%

Infographic: Key highlights from Sun Pharma Q3 2022 earnings results

January 31, 2022January 31, 2022

Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a growth of

Infographic: All you need to know about Dr Reddy’s Labs Q2 performance

December 14, 2021December 14, 2021

Dr. Reddy's Laboratories(NSE:DRREDDY) recently reported its second-quarter 2022 earnings results. The company had a consolidated revenue of ₹5,992 crores with a growth

Infographic: All you need to know about Divis Labs Q3 performance

December 10, 2021November 8, 2022

Divi's Laboratories(NSE: DIVISLABS) reported its second-quarter 2022 earnings release The company had net consolidated revenue of ₹2,006 crores with a growth of

Infographic: How Cipla performed in Q2 2022

December 6, 2021December 6, 2021

Cipla Limited(NSE: CIPLA) posted its second-quarter 2022 results. The company posted consolidated revenue of ₹5,580 crores with a growth of 9% year

Earnings: Aurobindo Pharma results in Q2 2022

November 8, 2021November 8, 2021

Aurobindo Pharma (NSE: AUROPHARMA) reported its second-quarter 2022 earnings results today. The company had a consolidated net profit of ₹696.71 crores with

Key highlights from Sun Pharma Q2 2022 earnings results

November 2, 2021November 2, 2021

Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its second-quarter 2022 earnings results today. The company reported consolidated revenue of ₹98.4 billion with a

Key highlights from Dr Reddy’s Q2 2022 earnings results

October 29, 2021October 29, 2021

Dr Reddy’s Laboratories (NSE: DRREDDY) reported its second-quarter financial results for the period ended September 30, 2021. The company had total revenue

How Cipla performed in Q2 2022

October 26, 2021October 26, 2021

The pharma giant Cipla (NSE: CIPL) reported its second-quarter 20223 earnings results on Tuesday after market hours. The total revenue increased by

Posts navigation

Older posts

© 2020 AlphaStreet Inc. All Rights Reserved

Quick Links

  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calls
  • Contact
  • Company
  • The Team

Contact Info

info@alphastreet.com

44053 Fremont Blvd,
Fremont, CA 94538

Top